期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

预防静脉桥再狭窄的基因治疗研究现状

Research status of gene therapy in preventing restenosis of vein bridge
下载PDF
导出
摘要 动脉粥样硬化导致的冠状动脉疾病是全世界疾病死亡的一个主要原因。对于轻度至中度或慢性稳定的冠状动脉疾病而言，药物疗法有助于控制症状并延缓疾病进展，但经皮介入治疗和冠状动脉旁路移植手术（coronary artery bypass graft，CABG）在急性或严重的情况下是必要的。
作者 张华锋 高荣
机构地区 内蒙古医科大学研究生学院 内蒙古医科大学附属医院心脏大血管外科
出处 《中国心血管病研究》 CAS 2016年第2期101-105,共5页 Chinese Journal of Cardiovascular Research
关键词 基因治疗 内膜增生 动脉粥样硬化 静脉桥再狭窄 Gene therapy Neointimal hyperplasia Atherosclerosis Vein graft restenosis
分类号 R543.6 [医药卫生—心血管疾病]
  • 相关文献

参考文献30

  • 1沈立,杨文钢,黄日太,薛松.并行循环下不停跳冠状动脉旁路移植术在冠心病患者中的应用[J].中国心血管病研究,2015,13(5):449-452. 被引量：10
  • 2Graham MM, Ghali WA, Faris PD, et al. Survival after coronary revascularization in the elderly. Circulation, 2002, 105 : 2378 - 2384.
  • 3Hate M, Sezai A, Niino T, et al. What is the optimal manage- ment for preventing saphenous vein graft disease:early results of intravascular angioscopic assessment. Circ J, 2007,71 : 286-287.
  • 4Murphy GJ, Angelini GD. Insights into the pathogenesis of vein graft disease:lessons from intravascular ultrasound. Cardiovascular ultrasound, 2004,2 : 8.
  • 5Alexander JH, Harley G, Harrington RA, et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for pre- vention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV : a randomized controlled trial. JAMA, 2005,294 : 2446-2454.
  • 6Mitra AK, Gangahar DM, Agrawal DK. Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft in- timal hyperplasia. Immunology and cell biology,2006,84:115-124.
  • 7Santel A, Aleku M, Keil O, et al. A novel siRNA-lipoplex tech- nology for RNA interference in the mouse vascular endothelium. Gene therapy, 2006,13 : 1222-1234.
  • 8Mann M J, Whittemore AD, Donaldson MC, et al. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. Lancet, 1999,354: 1493-1498.
  • 9Davda J, Labhasetwar V. Characterization of nanoparticle uptake by endothelial cells. Int J Pharm, 2002,233 : 51-59.
  • 10Schulick AH, Vassalli G, Dunn PF, et al. Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity. J Clin Invest, 1997,99 : 209-219.

二级参考文献29

  • 1Finkel MS, Oddis CV, Jacob TD, et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science, 1992, 257: 387.
  • 2Vassalli G, Dichek DA. Gene therapy for arterial thrombosis. Cardiovasc Res, 1997, 35:459.
  • 3Schneider MD, French BA. The advent of adenovirus gene therapy for cardiovascular disease. Circulation, 1993, 88:1937.
  • 4Ueno H, Li JJ, Tomita H, et al. Quantitative analysis of repeat adenovirus-mediated gene transfer into injured canine femoral arteries. Arterioscler Thromb Vasc Biol, 1995, 15: 2246.
  • 5Newman KD, Dunn PF, Owens JW, et al. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest, 1995, 96: 2955.
  • 6Fitzagibbon GM,Lrcp&s,Kafka HP,et al.Coronary bypass graft fate and patient outcome:angiogyaphic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years[].Journal of the American College of Cardiology.1996
  • 7Grondin CM,Campeau L,lesperance J,et al.Comparison of late changes in internal mammary grtery and subvenous vein crafts in two consecutive series of patients 10 years after operation[].Circulation.1984
  • 8Chello M,Mastroroberto P,perticone F,et al.Nitric oxide modulation of neutrophil endothelium interaction:difference between arterial and venous coronary bypass grafts[].Journal of the American College of Cardiology.1998
  • 9Lin MC,Fanny AJ,Chen HH,et al.Shear stress induction of the tissue factor gene[].The Journal of Clinical Investigation.1997
  • 10Barker JE,Anderson J,Treasure T, et al.Influence of endothelium and surgical preparation on responses of human saphenous vein and intemal thoracic artery to angiotensin Ⅱ[].British Journal of Clinical Pharmacology.1994

共引文献10

中国心血管病研究
2016年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部